5FELDMANN H, GEISBERT T W. Ebola haemorrhagic fever[J]. Lancet Infectious Diseases, 2011,377: 849-862.
6JOHANSEN L M, BRANNAN J M, DELOS S E, et al. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection[J]. Science Translational Medicine, 2013, 5(190): 1-13.
7RODDY P, HOWARD N, van KERKHOVE M D, et al. Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007- 2008[J]. PLoS ONE, 2012, 7(12). doi: 10.1371/journal.pone.0052986.
8HALFMANN P, KIM J H, EBIHARA H, et al. Generation of biologically contained Ebola viruses[J]. Proceedings of the National Academy of Sciences of the United States of America, 2008, 105(4): 1129-1133.
9GEISBERT T W, JAHRLING P B. Differentiation of filoviruses by electron microscopy[J]. Virus Research, 1995, 39(2/3): 129-150.
10SANCHEZ A, TRAPPIER S G, MAHYB W J, et al. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing[J]. Proceedings of the National Academy of Sciences of the United States of America, 1996, 93(8): 3602-3607.
